YU42367B - Process for obtaining basic esters - Google Patents

Process for obtaining basic esters

Info

Publication number
YU42367B
YU42367B YU3111/80A YU311180A YU42367B YU 42367 B YU42367 B YU 42367B YU 3111/80 A YU3111/80 A YU 3111/80A YU 311180 A YU311180 A YU 311180A YU 42367 B YU42367 B YU 42367B
Authority
YU
Yugoslavia
Prior art keywords
obtaining basic
basic esters
esters
obtaining
basic
Prior art date
Application number
YU3111/80A
Other languages
English (en)
Other versions
YU311180A (en
Inventor
Z Budai
L Magdanyi
A Lay
T Mezet
K Grasser
L Petrocz
I Kosoczky
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of YU311180A publication Critical patent/YU311180A/xx
Publication of YU42367B publication Critical patent/YU42367B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
YU3111/80A 1979-12-14 1980-12-10 Process for obtaining basic esters YU42367B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU79EE2715A HU179164B (en) 1979-12-14 1979-12-14 Process for producing cycloalkyl-ethers of alkanolamines

Publications (2)

Publication Number Publication Date
YU311180A YU311180A (en) 1983-10-31
YU42367B true YU42367B (en) 1988-08-31

Family

ID=10995882

Family Applications (1)

Application Number Title Priority Date Filing Date
YU3111/80A YU42367B (en) 1979-12-14 1980-12-10 Process for obtaining basic esters

Country Status (27)

Country Link
US (1) US4342762A (xx)
JP (1) JPS56123953A (xx)
AT (1) AT374449B (xx)
AU (1) AU539173B2 (xx)
BE (1) BE886579A (xx)
CA (1) CA1155115A (xx)
CH (1) CH649986A5 (xx)
CS (1) CS216544B2 (xx)
DD (1) DD155320A5 (xx)
DE (1) DE3047142C2 (xx)
DK (1) DK156825C (xx)
ES (1) ES8200857A1 (xx)
FI (1) FI76783C (xx)
FR (1) FR2471968B1 (xx)
GB (1) GB2065122B (xx)
GR (1) GR72509B (xx)
HU (1) HU179164B (xx)
IE (1) IE51733B1 (xx)
IL (1) IL61685A (xx)
IT (1) IT1209377B (xx)
NL (1) NL193907C (xx)
NO (1) NO150638C (xx)
PL (1) PL127036B1 (xx)
SE (1) SE451132B (xx)
SU (1) SU1253425A3 (xx)
UA (1) UA5566A1 (xx)
YU (1) YU42367B (xx)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242934A (en) * 1992-03-02 1993-09-07 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5212188A (en) * 1992-03-02 1993-05-18 R. J. Reynolds Tabacco Company Method for treatment of neurodegenerative diseases
US5242935A (en) * 1992-03-06 1993-09-07 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5288872A (en) * 1992-03-13 1994-02-22 Wake Forest University Compounds for treatment of neurodegenerative diseases
US5227385A (en) * 1992-03-13 1993-07-13 Wake Forest University Method for treatment of neurodegenerative diseases
US5187169A (en) * 1992-04-10 1993-02-16 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5276043A (en) * 1992-04-10 1994-01-04 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5214060A (en) * 1992-04-10 1993-05-25 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5232932A (en) * 1992-05-21 1993-08-03 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5248690A (en) * 1992-07-07 1993-09-28 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5242916A (en) * 1992-07-07 1993-09-07 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
JPH0626170A (ja) * 1992-07-09 1994-02-01 Yodogawa Steel Works Ltd 壁板材の取付構造
JPH06193226A (ja) * 1992-12-26 1994-07-12 Yodogawa Steel Works Ltd 壁板材の取付構造
KR100381558B1 (ko) * 1994-07-01 2003-08-19 에지스 지오기스제르기아르 알티. 약제조성물및이의제조방법
HU214588B (hu) * 1994-07-01 1998-04-28 EGIS Gyógyszergyár Rt. Eljárás bicikloheptán-származékot tartalmazó, CCK-rendszer gátló hatású gyógyászati készítmények előállítására
US5652270A (en) * 1994-07-01 1997-07-29 Egis Gyogyszergyar Rt Pharmaceutical compositions containing bicycloheptane ether amines and a process for the preparation thereof
US5583140A (en) * 1995-05-17 1996-12-10 Bencherif; Merouane Pharmaceutical compositions for the treatment of central nervous system disorders
HU226061B1 (en) * 1996-10-17 2008-04-28 Egis Gyogyszergyar Nyilvanosan 1,7,7-trimethyl-bicyclo[2.2.1]heptane derivative, pharmaceutical compositions containing the same and process for their preparation
HUP9900445A2 (hu) * 1999-02-24 2001-06-28 EGIS Gyógyszergyár Rt. Eljárás (1R,2S,4R)-(-)-N,N-(dimetilamino-etoxi)-2-fenil-1,7,7-trimetil-biciklo[2.2.1]heptán előállítására és ennek köztiterméke
HU227114B1 (en) * 1999-05-11 2010-07-28 Egis Gyogyszergyar Nyilvanosan (1r, 2s, 4r)-(-)-2-[n,n-(dimethylamino-ethoxy)]-2-phenyl-1,7,7-trimethyl-bicyclo[2.2.1]heptane of high purity and pharmaceutically acceptable acid addition salts thereof, process for preparation of them and medicaments containing the same
US6335372B1 (en) * 2000-11-28 2002-01-01 Orion Corporation Treatment of obsessive compulsive disorder
FI20002612A0 (fi) * 2000-11-28 2000-11-28 Orion Yhtymae Oyj Yhdistelmäterapia serotoniinivälityksen häiriöiden hoitamiseksi
HUP0103017A3 (en) * 2001-07-18 2004-05-28 Egis Gyogyszergyar Nyilvanosan Pharmaceutical composition for the treatment of diseases caused by impairment of cognitive functions and its use
GB0306604D0 (en) * 2003-03-21 2003-04-30 Curidium Ltd Second medical use
WO2004084905A2 (en) * 2003-03-24 2004-10-07 University Of Florida Use of 5-ht2c receptor activity affecting compounds for treating idiopathic hyperhidrosis and associated conditions
HUP0301537A3 (en) * 2003-06-03 2005-07-28 Egis Gyogyszergyar Nyilvanosan Deramcyclane fumarate tablets and process for producing them
KR101493508B1 (ko) * 2013-02-18 2015-02-16 오스템임플란트 주식회사 치아 미백 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL246462A (xx) * 1959-08-06
GB895050A (en) * 1960-01-29 1962-04-26 Boehringer & Soehne Gmbh New basic ethers
DE1108684B (de) * 1960-01-29 1961-06-15 Boehringer & Soehne Gmbh Verfahren zur Herstellung neuer basischer AEther
AT264495B (de) * 1963-08-18 1968-09-10 Egyt Gyogyszervegyeszeti Gyar Verfahren zur Herstellung von neuen basischen Cycloheptanoläthern
GB1085969A (en) * 1965-08-11 1967-10-04 Glidden Co Insectiphobic compositions comprising terpene derivatives
US4118499A (en) * 1975-10-15 1978-10-03 Glaxo Laboratories Limited Anti-anxiety and anti-parkinsonian 1-aminoalkyl-2-endo-chloro-7,7-dimethylnorbornanes
JPS6034925B2 (ja) * 1979-07-31 1985-08-12 帝人株式会社 持続性鼻腔用製剤およびその製造法

Also Published As

Publication number Publication date
FI803858L (fi) 1981-06-15
GB2065122A (en) 1981-06-24
IE802612L (en) 1981-06-14
IL61685A0 (en) 1981-01-30
IE51733B1 (en) 1987-03-18
IT1209377B (it) 1989-07-16
DE3047142A1 (de) 1981-09-10
DE3047142C2 (de) 1985-09-26
AU539173B2 (en) 1984-09-13
CH649986A5 (de) 1985-06-28
ES497717A0 (es) 1981-11-16
DK156825B (da) 1989-10-09
JPS6314703B2 (xx) 1988-04-01
JPS56123953A (en) 1981-09-29
HU179164B (en) 1982-08-28
CA1155115A (en) 1983-10-11
SE451132B (sv) 1987-09-07
YU311180A (en) 1983-10-31
FI76783B (fi) 1988-08-31
GB2065122B (en) 1983-06-29
NL8006722A (nl) 1981-07-16
FR2471968B1 (fr) 1986-08-22
NO150638B (no) 1984-08-13
DK528980A (da) 1981-06-15
BE886579A (fr) 1981-06-10
NO803764L (no) 1981-06-15
CS216544B2 (en) 1982-11-26
NO150638C (no) 1984-11-21
FR2471968A1 (fr) 1981-06-26
US4342762A (en) 1982-08-03
AT374449B (de) 1984-04-25
IT8026587A0 (it) 1980-12-12
GR72509B (xx) 1983-11-16
SU1253425A3 (ru) 1986-08-23
DD155320A5 (de) 1982-06-02
PL127036B1 (en) 1983-09-30
NL193907B (nl) 2000-10-02
UA5566A1 (uk) 1994-12-28
AU6529380A (en) 1981-06-18
ES8200857A1 (es) 1981-11-16
DK156825C (da) 1990-03-12
SE8008680L (sv) 1981-06-15
ATA601380A (de) 1983-09-15
FI76783C (fi) 1988-12-12
NL193907C (nl) 2001-02-05
IL61685A (en) 1984-10-31
PL228392A1 (xx) 1981-08-07

Similar Documents

Publication Publication Date Title
YU311180A (en) Process for obtaining basic esters
YU11380A (en) Process for obtaining n-benzyl-imidazole
DE3062324D1 (en) Process for producing n-acyl-d-phenylalanine ester
YU136780A (en) Process for obtaining new 3-thiovinyl-cephalosporins
JPS53119816A (en) Process for preparing buthanedicarboxylic ester
YU136980A (en) Process for obtaining new vinyl-3-cephalosporins
YU65680A (en) Process for obtaining 9-amino-alkylfluorene
YU177880A (en) Process for obtaining acyl-carbamides
JPS545938A (en) Process for preparing 22arylalkanic ester
YU116380A (en) Process for obtaining thiazolylidene-oxo-propionitrile
YU73083A (en) Process for obtaining 2-amino-3-benzoyl-phenylacetamides
YU13180A (en) Process for obtaining spiro-quinolyl-hydantoin
EP0049911B1 (en) Process for preparing alpha-hydroxybenzylphosphonic-acid esters
YU108580A (en) Process for obtaining alkoxyalkylidene hydrazinopyridazine
JPS53147100A (en) Process for preparing apopincamic ester
YU259680A (en) Process for obtaining acylcarbamides
YU44734B (en) Process for obtaining 3-halogen-cephalosporin iminohalogenids
YU63980A (en) Process for obtaining n-sulfinyl-carbamates
JPS53138000A (en) Process for preparing apopincamic ester
DE3060733D1 (en) Process for preparing pivaloyl-acetic-acid esters
YU276480A (en) Process for obtaining omega-lactams
YU182480A (en) Process for obtaining alpha-aryl-propionic acids
YU90680A (en) Process for obtaining hydroxyimino-substituted aminoacetonitriles
YU43221B (en) Process for obtaining imidazobenzodiazepine
YU310680A (en) Process for obtaining vanadyl-hydrate